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Neurons use neurotransmitters to communicate
across synapses, constructing neural circuits in the
brain. AMPA-type glutamate receptors are the
predominant excitatory neurotransmitter receptors
mediating fast synaptic transmission. AMPA recep-
tors localize at synapses by forming protein
complexes with transmembrane AMPA receptor
regulatory proteins (TARPs) and PSD-95-like
membrane-associated guanylate kinases. Among
the three classes of ionotropic glutamate receptors
(AMPA, NMDA, and kainate type), AMPA receptor
activity is most regulatable by neuronal activity to
adjust synaptic strength. Here, we mutated the
prototypical TARP, stargazin, and found that TARP
phosphorylation regulates synaptic AMPA receptor
activity in vivo. We also found that stargazin interacts
with negatively charged lipid bilayers in a phosphory-
lation-dependent manner and that the lipid interac-
tion inhibited stargazin binding to PSD-95. Cationic
lipids dissociated stargazin from lipid bilayers and
enhanced synaptic AMPA receptor activity in a star-
gazin phosphorylation-dependent manner. Thus,
TARP phosphorylation plays a critical role in regu-
lating AMPA receptor-mediated synaptic transmis-
sion via a lipid bilayer interaction.
INTRODUCTION
Neurons communicate at synapses through neurotransmitters,
and amajor excitatory neurotransmitter in the brain is glutamate.
AMPA-type glutamate receptorsmediate fast synaptic transmis-
sion. Among the three classes of ionotropic glutamate receptors
(AMPA, NMDA, and kainate type), AMPA receptor activity is the
most highly regulated by neuronal activity, which serves to adjust
synaptic strength (Collingridge et al., 2004; Kessels and Mali-
now, 2009; Lisman, 2003; Malenka and Bear, 2004; Nelson and
Turrigiano, 2008). Neuronal activity regulates synaptic strength
by controlling the numbers of AMPA receptor at synapses
(Collingridge et al., 2004; Kessels and Malinow, 2009; Lisman,2003; Malenka and Bear, 2004; Nelson and Turrigiano, 2008;
Newpher and Ehlers, 2008; Shepherd and Huganir, 2007).
The characteristic structure of excitatory synapses is the post-
synaptic density (PSD), which is observed as an electron-dense
area underlying the postsynaptic membrane. The PSD-enriched
prototypical PDZ protein, PSD-95, is a membrane-associated
guanylate kinase (MAGUK) that contains three PDZ domains
(Cho et al., 1992). Overexpression of PSD-95 in hippocampal
neurons was found to drive the maturation of excitatory
synapses, as shown by enhanced synaptic clustering and
activity of AMPA receptors (El-Husseini et al., 2000). Acute
knockdown of PSD-95 expression by RNAi revealed a specific
loss of AMPA receptor-mediated excitatory postsynaptic
currents (EPSCs) (Beique and Andrade, 2003; Elias et al.,
2006; Nakagawa et al., 2004; Schluter et al., 2006). Furthermore,
targeted disruption of PSD-95 in mice alters synaptic plasticity
such that long-term potentiation (LTP) is enhanced and long-
term depression is eliminated (Migaud et al., 1998). LTP was
occluded in hippocampal neurons in which PSD-95 was overex-
pressed (Ehrlich and Malinow, 2004; Stein et al., 2003). Impor-
tantly, although PSD-95 cannot directly interact with AMPA
receptors, it nevertheless specifically enhances AMPA receptor
activity.
AMPA receptors contain transmembrane AMPA receptor
regulatory proteins (TARPs) as their auxiliary subunits (Coombs
and Cull-Candy, 2009; Nicoll et al., 2006; Osten and Stern-Bach,
2006; Sager et al., 2009; Ziff, 2007). TARPs are classified as class
I (stargazin/g-2, g-3, g-4, and g-8) and class II (g-5 and g-7) and
are evolutionally conserved (Kato et al., 2008; Tomita et al., 2003;
Wang et al., 2008). TARPs interact with AMPA receptors and
modulate trafficking, channel activity, and pharmacology of
AMPA receptors (Chen et al., 2000; Cho et al., 2007; Kato
et al., 2007; Kott et al., 2007; Menuz et al., 2007; Milstein et al.,
2007; Priel et al., 2005; Soto et al., 2007; Tomita et al., 2005a,
2006; Turetsky et al., 2005). Furthermore, TARPs binds to
PSD-95-like MAGUKs to stabilize the AMPA receptor /TARP
complex at synapses (Bats et al., 2007; Chen et al., 2000; Dakoji
et al., 2003). AMPA receptor-mediated synaptic transmission is
reduced in the cerebellar granule cells from stargazer mice in
which the prototypical TARP stargazin/g-2 is disrupted and in
the hippocampal pyramidal cells of TARP/g-8 knockout mice
(Hashimoto et al., 1999; Rouach et al., 2005). Furthermore,
TARP triple knockout mice (g-2/3/4 and g-2/3/8) were dead after
birth, indicating the necessity of TARPs for postnatal survivalNeuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc. 755
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A CB Figure 1. Stargazin Phosphorylation Regu-
lates Synaptic Localization of Stargazin
All nine phosphorylated serine residues of starga-
zin (STG) were mutated to either aspartate (phos-
phomimic; StargazinSD) or alanine (non-phospho-
mimic; StargazinSA) in knockin mice.
(A) Lambda phosphatase treatment (PPase) low-
ered the molecular weight of stargazin from wild-
type mice (WT), but not from StargazinSD (SD) or
StargazinSA mice (SA). Western blots performed
with three different anti-stargazin antibodies
showed similar patterns.
(B and C)Western blots of fractionated brains from
WT (B) and StargazinSD/StargazinSA hemizygous mice (C) showed that stargazin in synaptic fraction (PSD) migrated as higher molecular weight than that in
non-synaptic fraction (Syn/Tx) (B).
(C) StargazinSDwashighly enriched in thePSD fraction,whereasStargazinSAwasdistributedevenly between thePSDandTritonX-100-soluble synaptosome (Syn/
Tx) fractions. Sph, synaptophysin; Geno, genotype.
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Lipids Regulate AMPA Receptors through TARPs(Menuz et al., 2009). These results indicate that AMPA receptors
localize at synapses by forming protein complexes with TARPs
and PSD-95-like MAGUKs. However, it remains unclear as to
how neuronal activity modulates the number of AMPA receptors
at synapses.
Synaptic targeting of AMPA receptors has been suggested to
be regulated by TARPs (Tomita et al., 2005b; Tsui and Malenka,
2006). TARPs are highly phosphorylated at synapses and their
phosphorylation is regulated bidirectionally upon neuronal
activity (Inamura et al., 2006; Tomita et al., 2005b). Furthermore,
neuronal synaptic AMPA receptor activity at synapses is
enhanced by overexpression of a TARP mutant that mimics
the phosphorylated state of TARPs (Kessels et al., 2009; Tomita
et al., 2005b).
In this study, we explored the mechanisms regulating the
activity of synaptic AMPA receptors and determined that TARPs
interact with negatively charged lipid bilayers in a TARP
phosphorylation-mediated manner. TARP phosphorylation
modulates synaptic AMPA receptor activity in vivo using TARP
knockins carrying mutations in their phosphorylation sites. Inter-
action of lipids with TARPs inhibits TARP binding to PSD-95,
which is required for synaptic localization of the AMPA
receptor/TARP complex. Furthermore, cationic lipids dissociate
TARPs from lipid bilayers and increase the activity of synaptic
AMPA receptors in a TARP phosphorylation-dependent manner.
Therefore, we conclude that the synaptic activity of AMPA recep-
tors is controlled by TARP phosphorylation via PSD-95 binding,
which is modulated by the TARP-lipid bilayer interaction.
RESULTS
TARP Phosphorylation Increases AMPA Receptor
Activity at Synapses
The prototypical TARP (stargazin) at the PSD is highly phos-
phorylated (Tomita et al., 2005b). Nine serine residues located
in a short consecutive region of the stargazin cytoplasmic
domain were identified previously (Tomita et al., 2005b). To
examine the roles played by TARP phosphorylation in vivo,
we generated knockin mice containing mutations in the proto-
typical TARP—stargazin. Phosphorylated stargazin at the PSD
migrated at a molecular weight that was similar to that of the
StargazinSD mutant, in which the nine phosphorylatable serine756 Neuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc.residues were mutagenized to aspartate (phosphomimic
mutant) (Tomita et al., 2005b). To examine how many of the
nine phosphorylatable serine residues in stargazin were phos-
phorylated at synapses, we examined the shifts in molecular
weight of each stargazin mutant using SDS-PAGE (Figures
S1A and S1B). We found that StargazinSD migrated at a higher
molecular weight compared with StargazinSA in a number of
phosphomimic mutation-dependent manners (Figure S1A) and
that no single phosphomimic mutation caused dramatic shifts
in the molecular weight of StargazinSD (Figure S1B). Impor-
tantly, the molecular weight of StargazinSD was larger than that
of three distinct stargazin mutants that carry six phosphomimic
mutations at different phosphorylatable serine residues, which
suggests that the stargazin molecules located at synapses
are phosphorylated at least at seven sites (Figure S1A). To
examine the roles of stargazin phosphorylation, we mutated all
nine phosphorylatable serine residues to aspartate (phosphomi-
mic, StargazinSD) or alanine (non-phosphomimic, StargazinSA;
Figures S1C–S1E). Following lambda phosphatase treatment,
wild-type stargazin shifted to a lower molecular weight (Fig-
ure 1A). In contrast, the molecular weights of mutated proteins
from StargazinSD and StargazinSA mice remained unchanged
and corresponded to the molecular weights for phosphorylated
and non-phosphorylated stargazin, respectively (Figure 1A).
These results were confirmed using three different antibodies
against stargazin (Figure 1A). Both StargazinSD and StargazinSA
homozygous mice are fertile and viable and did not exhibit
changes in protein expression of synaptic proteins, which
included stargazin, AMPA receptors (GluA1–4), NMDA receptor
(GluN1), and MAGUKs (PSD-93 and -95 and SAP97 and 102)
(FigureS1F). Toexaminehow the stargazinphosphorylation state
affects its distribution,we fractionatedbrains fromwild-typemice
and heterozygous StargazinSD and StargazinSA mice. Wild-type
stargazin was highly phosphorylated in the PSD fraction (Tomita
et al., 2005b) (Figure 1B). StargazinSD fractionated predominantly
into the PSD fraction, whereas StargazinSA fractionated evenly
into both the PSD and Triton X-100-soluble non-synaptic frac-
tions, which indicates that the phosphorylation of stargazin
modulates its synaptic distribution in vivo (Figure 1C).
Next we explored changes in AMPA receptor activity in cere-
bellar granule neurons, in which stargazin is the only TARP ex-
pressed (Chenet al., 2000; Hashimoto et al., 1999).Wemeasured
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Figure 2. Stargazin Phosphorylation Modulates AMPA Receptor Activity in Cerebellar Mossy Fiber/Granule Cell Synapses In Vivo
(A) EPSCs elicited by mossy fiber stimulation were recorded in cerebellar granule cells from wild-type (WT), stargazer (STG), and stargazin knockin mice (SA and
SD). The AMPA receptor component of EPSCs (IAMPA) was measured as the peak amplitude at a holding potential of –70 mV and the NMDA receptor component
(INMDA) was measured at a holding potential of +40 mV and at 50 ms latency. The ratio of IAMPA to INMDA was increased by 75% in StargazinSD mice compared
with wild-type mice (p < 0.01; n = 6 for wild-type mice and n = 7 for StargazinSD mice) and reduced by 38% in StargazinSA mice compared with wild-type mice
(p < 0.01; n = 6 for wild-type mice and n = 6 for StargazinSA mice). The IAMPA was invisible in stargazer mice (n = 6). Sample traces of EPSCs are shown in (A) at
a holding potential of –70 mV (bottom) or +40 mV (top). Scale bars, 20 ms and 40 pA (WT), 10 pA (STG), 20 pA (SA), and 50 pA (SD).
(B and C) I-V relationships of mossy fiber EPSCs from each genotype, measured at the peak of (B) and 50 ms (C) after the stimulus. The EPSC amplitudes were
normalized to the mean value at +50 mV in each genotype (n = 6–7).
(D) Paired-pulse facilitation (PPF) values measured at 40 ms intervals did not differ among the genotypes (n = 6–7).
(E–G) mEPSCs recorded from cerebellar granule cells in acute cerebellar slices at a holding potential of –70 mV in the presence of 1 mM TTX. Sample traces are
shown in (E).
(F) Cumulative distribution of mEPSC amplitudes and average mEPSC amplitude (small inset). The mEPSC amplitude was significantly larger in StargazinSD mice
compared with wild-type mice (p < 0.01, Kolmogorov-Smirnov test for cumulative distribution; p < 0.01, one-way ANOVA for average; n = 10 for wild-type mice
and n = 11 for StargazinSD mice), whereas it was significantly smaller in StargazinSA mice compared with wild-type mice (p < 0.01, Kolmogorov-Smirnov test for
cumulative distribution; p < 0.05, one-way ANOVA for average; n = 10 for wild-type mice and n = 9 for StargazinSA mice).
(G) However, the time intervals between events were not significantly different among the genotypes. Error bars in all graphs represent the SEM.
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Lipids Regulate AMPA Receptors through TARPsthe excitatory synaptic transmission at cerebellar mossy fiber/
granule cell synapses using acute cerebellar slices (Figure 2).
The AMPA receptor component of EPSCs (IAMPA) was measured
as the peak amplitude at a holding potential of –70 mV, whereas
the NMDA receptor component of EPSCs (INMDA) was measured
at aholdingpotential of +40mVandat a50ms latency.Wedidnot
detect anAMPA receptor component of EPSCselicitedbymossy
fiber stimulation in neurons from stargazer mice (Figure 2A), as
published previously (Hashimoto et al., 1999). The ratio of the
AMPA receptor to the NMDA receptor components of EPSCs
was measured among different genotypes; we found that theAMPA/NMDA receptor ratio was increased by 75% in Starga-
zinSDmice and decreased by 38% inStargazinSAmice compared
with wild-type animals (Figure 2A), without changes in I-V rela-
tionships and paired-pulse facilitation (40 ms interval) (Figures
2B–2D). These results strongly indicate that postsynaptic proper-
ties were altered in stargazin-phosphorylated knockin animals.
To test this directly, we measured miniature EPSCs (mEPSCs)
using 1 mM tetrodotoxin (Figure 2E). We did not detect any
obvious events in cerebellar granule cells from stargazer mice
(Figure 2E). mEPSC amplitudes were significantly larger in Star-
gazinSD than in StargazinSA mice and the mEPSC amplitudesNeuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc. 757
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Lipids Regulate AMPA Receptors through TARPsdetected in wild-type mice were intermediate to those observed
for the twoknockinmice,with a less steep cumulative probability,
which suggests the presence of synaptic heterogeneity in wild-
type neurons (Figure 2F). Moreover, interevent intervals (mEPSC
frequency) were not different among different genotypes
(Figure 2G). These results indicate that AMPA receptor activity
was increased at synapses of StargazinSD animals and
decreased at synapses of StargazinSA mice.
In addition to the evaluation of synaptic transmission in acute
cerebellar slices, we also examined synaptic transmission in
primary cultures of cerebellar granule cells. To avoid complexity
from experimental conditions, we used a mixed population of
cerebellar granule neurons from homozygous StargazinSA and
StargazinSD mice on each plate. To identify genotype, either
mouse carries the extra GFP transgene by mating GFP trans-
genic mice and stargazin knockins. We measured AMPA
receptor-mediated mEPSCs (Figure S2A). Neurons from Starga-
zinSD mice exhibited significantly larger amplitudes of AMPA
receptor-mediated mEPSCs than StargazinSA neurons but no
significant difference in frequency or decay kinetics of mEPSCs
(Figures S2B–2E). These results indicate that more AMPA recep-
tors localize at synapses of StargazinSD mice than StargazinSA
mice, which is consistent with findings that were obtained using
acute cerebellar slices (Figure 2). To examine AMPA receptor
activity at the cell surface, we measured AMPA-evoked currents
and found that neurons from StargazinSD mice exhibited signifi-
cantly larger AMPA-evoked currents compared with those from
wild-type or StargazinSA mice (Figure S2F). Whereas AMPA-
evoked currents in wild-type and StargazinSA mice were at
similar level, mEPSC amplitude in wild-type is larger than one
in StargazinSA, indicating that StargazinSA expressed at the cell
surface but trapped outside of synapses.
Stargazin Binds Negatively Charged Lipids
in a Phosphorylation-Dependent Manner
We next explored the mechanism underlying preferential
synaptic localization of StargazinSD. A simple model might
predict that a molecule interacting with stargazin in a phosphor-
ylation-dependent manner would regulate localization of the
stargazin/AMPA receptor complex. To search for such a mole-
cule, we initially took a proteomic approach, copurifying AMPA
receptors with stargazin from both StargazinSD and StargazinSA
mice (Figure S3B). However, silver staining did not detect
obvious interactors with stargazin in a phosphorylation-depen-
dent manner in detergent-soluble brain lysates (Figure S3A).
Therefore, we next examined whether lipids interacted with star-
gazin. We purified the GST-tagged cytoplasmic domain of star-
gazin and overlaid it onto a membrane spotted with various
lipids. Interaction with stargazin was detected with negatively
charged lipids including phosphatidic acid (PA), phosphatidyli-
nositol-4-phosphate (PIP), phosphatidylinositol-4,5-biphos-
phate (PIP2), and phosphatidylinositol-3,4-5-triphosphate (PIP3)
(Figure 3A). Interactions were observed between lipids and star-
gazin wild-type/StargazinSA, but not StargazinSD (Figure 3A). We
then examined interaction of stargazin with liposome—more
native forms of lipids. Liposomes containing phosphatidylcho-
line (PC) alone, or with various other lipids (9:1), were mixed
with the thioredoxin-tagged cytoplasmic domain of stargazin.758 Neuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc.Sucrose gradient centrifugation was used to separate lipo-
some-bound stargazin from the unbound protein. We detected
interactions between stargazin and liposomes containing nega-
tively charged (PIP2 or PA) or polar lipids (phosphatidylserine
or phosphatidylglycerol); interactions were not observed with
neutrally charged lipids [phosphatidylethanolamine (PE) or PC;
Figures 3B and 3C]. The difference in results using polar lipids
between a lipid strip assay and a liposome binding assay arose
from the properties of polar lipids in that liposomes containing
polar lipids can be negatively charged at their surface because
of the directional alignment of polar lipids, whereas polar lipids
aligned randomly on lipid strips are neutral. Importantly, wild-
type stargazin and StargazinSA bound the PA/PC liposome,
whereas StargazinSD did not (Figures 3D and 3E). Furthermore,
eight positively charged amino acids (arginines) are located
around the phosphorylatable serine residues in stargazin. To
examine the role of positively charged residues in the interaction
of stargazin with negatively charged lipid bilayers, we replaced
the eight arginine residues with seven leucine residues and one
glycine residue (RL). We found that StargazinRL did not interact
with negatively charged liposomes (Figure 3F). These experi-
ments establish that stargazin interactswith a negatively charged
lipid bilayer in a phosphorylation- and electrostatic-dependent
manner.
Lipid Bilayers Inhibit Binding of Stargazin to PSD-95
It has been shown that the four C-terminal amino acids of starga-
zin bind PDZ domains of PSD-95-like MAGUKs, which scaffold
signaling molecules at synapses (Bats et al., 2007; Chen et al.,
2000; Dakoji et al., 2003; Schnell et al., 2002). To examine how
stargazin phosphorylation affects its ability to bind to PSD-95,
the cytoplasmic domain of stargazin was mixed with GST-fused
PSD-95 (PDZ domains 1–3), followed by recovery of GST-fused
proteins with glutathione beads to separate the PSD-95-binding
fraction. Stargazin mutants lacking the last four amino acids (D4)
did not interact with PSD-95, whereas both StargazinSD and
StargazinSA interacted with PSD-95 to a similar extent (Fig-
ure 4A). Thus, stargazin phosphorylation does not affect interac-
tion with PSD-95 in the absence of lipids.
Next, we examined the effects of lipid interaction on bind-
ing between stargazin and PSD-95. Stargazin proteins were
covalently conjugated to liposomes containing 4-(p-maleimido-
phenyl)butyramide (MPB)-PE via the MPB-cysteine thiol-malei-
mide reaction, to avoid complications arising from direct inter-
action between StargazinSA and the liposome (Figure 4B). After
washing with 1 M NaCl to remove non-conjugated proteins from
liposomes, stargazin-conjugated liposomes were mixed with
PSD-95, followed by separation of bound and unbound PSD-95
by sucrose gradient centrifugation (Figure 4B; see detailed
method in Figure S4A). Conjugated StargazinSD and Starga-
zinSA could be detected following incorporation of MPB-PE
into PC/PA (Figure 4C, first and second lanes). Furthermore,
to reconstitute lipid composition in the brain, we performed a
similar experiment using liposomes from a brain lipid extract
(Figure 4C, bottom panel). PSD-95 bound StargazinSD in both
types of liposomes. In contrast, PSD-95 did not bind to Starga-
zinSA or to StargazinSD lacking the four C-terminal amino acids
(D4; Figure 4C). Furthermore, StargazinRL conjugated to
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Figure 3. Stargazin Binds Negatively
Charged Lipids in a Phosphorylation-
Dependent Manner
(A) The cytoplasmic domain of stargazin (STG)
binds directly to PA and phosphoinositides (PIP,
PIP2, and PIP3). GST-fused stargazin cytoplasmic
domains were overlaid on a membrane spotted
with various lipids and bound stargazin was de-
tected with anti-GST antibody. TG, triglyceride;
DAG, diacylglycerol; PA, phosphatidic acid; PS,
phosphatidylserine; PE, phosphatidylethanol-
amine; PC, phosphatidylcholine; PG, phosphati-
dylglycerol; CL, cardiolipin; PI, phosphatidylinosi-
tol; PIP, phosphatidylinositol 4-phosphate; PIP2,
phosphatidylinositol 4,5-biphosphate; PIP3, phos-
phatidylinositol 3,4,5-triphosphate; C, cholesterol;
SM, sphingomyelin; ST, 3-sulfogalactosylcera-
mide.
(B) The cytoplasmic domain of stargazin recog-
nizes negatively charged liposomes. Thioredoxin
(Trx)-fused stargazin cytoplasmic domains were
mixed with liposomes containing phosphatidyl
choline (PC) and various lipids (9:1). Subsequently,
liposome-bound and unbound proteins were
separated by sucrose gradient centrifugation and
examined by western blotting.
(C) Quantitation of liposome-bound proteins
normalized against PIP2/PC-binding stargazin.
(D) The cytoplasmic domain of stargazin interacts
with PC/PA liposomes in a phosphorylation-
dependent manner. PC/PA liposomes interact
with thioredoxin-fused cytoplasmic domains of
stargazin and StargazinSA, but not StargazinSD.
(E) Quantitation of liposome-bound proteins
normalized against stargazin.
(F) The cytoplasmic domain of stargazin interacted
with PC/PA liposomes via its positively charged
residues (arginines). Eight of the arginine residues
located around the stargazin phosphorylation sites
and all arginine residues were replaced with seven leucines and one glycine residue (RL). PC/PA liposomes interacted with the thioredoxin-fused cytoplasmic
domain of stargazin (STG), but not StargazinRL, which indicates that the cytoplasmic domain of stargazin interacted with lipid bilayers via an electrostatic inter-
action. Error bars in (C) (n = 3) and (E) (n = 5) show means ± SEM.
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Lipids Regulate AMPA Receptors through TARPsliposomes interacted with PSD-95, independently from starga-
zin phosphorylation and the presence of negatively charged
lipids (Figure S4B), which suggests that the electrostatic inter-
action of stargazin with negatively charged lipid bilayers in-
hibited the binding of stargazin to PSD-95. Thus, lipids disrupt
binding of stargazin to PSD-95 and phosphorylation of starga-
zin enables dissociation from lipids, which allows binding of
PSD-95.
PSD-95 Binding Requires Stargazin Dissociation
from Lipid Bilayers
Since the interaction between StargazinSA and the negatively
charged lipid bilayer inhibits stargazin binding to PSD-95, the
binding could be increased upon neutralization of the lipid
bilayer charge to induce dissociation of stargazin from lipid
bilayers. We added the cationic lipid lipofectamine (3:1 mixture
of the cationic lipid DOSPA and of the neutral lipid DOPE,
according to the Invitrogen website) to mixtures of stargazin-
conjugated liposomes and PSD-95, and then separated starga-
zin-bound PSD-95 from the unbound protein (Figure 5A).Cationic lipids dramatically increased binding between PSD-95
and StargazinSA, but not StargazinSA D4 (Figure 5B). Interaction
between StargazinSD and PSD-95 was unaffected by addition
of cationic lipids (Figure 5B). We detected a weak signal for
bothStargazinSAD4 andStargazinSDD4 at a level thatwas similar
to that of liposomes conjugated with cysteine alone, which indi-
cates that this weak signal is non-specific after addition of
cationic lipids (Figure S5A). These results indicate that cationic
lipids neutralize the negatively charged lipid bilayer, which allows
stargazin to dissociate from the liposome and bind to PSD-95.
Next, we explored the effect of cationic lipids on electrostatic
interaction of stargazin with lipid bilayers. We needed to deliver
cationic lipids from the extracellular solution to the inner leaflet
of plasma membranes in neurons. We examined the effects of
various cationic lipids on net charges of the inner leaflet of
CHO cells using GFP-fused basic proteins that recognize nega-
tively charged lipids (GFP-R-pre) (Yeung et al., 2008). The
cationic lipids sphingosine and squalamine translocate GFP-R-
pre from the plasma membrane to the cytosol as reported previ-
ously (Yeung et al., 2006, 2008), whereas lipofectamine does notNeuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc. 759
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Figure 4. Lipid Bilayers Inhibit Binding of Stargazin to PSD-95
(A) In the absence of lipids, the four C-terminal amino acids of StargazinSD (SD)
and StargazinSA (SA) bind PSD-95. The PSD-95 PDZ domain-bound and
unbound stargazin (STG) cytoplasmic domains were separated with gluta-
thione beads. Both StargazinSD and StargazinSA bound to the PDZ domain,
whereas mutants lacking the last four amino acids (D4) did not bind.
(B) This diagram shows the experimental scheme to examine the effects of
lipid bilayers on the stargazin binding to PSD-95. Liposomes conjugated to
the stargazin cytoplasmic domain were incubated with the PSD-95 PDZ
domains. Stargazin-bound and unbound PSD-95 were separated by sucrose
gradient centrifugation.
(C) Lipid bilayers inhibit stargazin interaction with PSD-95. Stargazin did not
conjugate with liposomes lacking MPB-PE (MPB). The PSD-95 PDZ domains
bound liposomes conjugated with StargazinSD but not StargazinSA or Starga-
zinSD D4. Liposomes constituted with PC/PA or brain lipids showed similar
results.
Neuron
Lipids Regulate AMPA Receptors through TARPs(Figure S5B). However, sphingosine could not be used for lipo-
some experiments, since incorporation efficiency of sphingosine
into 100 nm liposomes seems low. Thus, we used sphingosine
as a cationic lipid to examine its effects on the electrostatic
interaction of stargazin with lipid bilayers. Stargazin is a tetra-
membrane-spanning protein. As it is difficult to use full-length
transmembrane proteins to evaluate the roles of its cytoplasmic760 Neuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc.domain in lipid interaction and distribution, we expressed the
GFP-tagged cytoplasmic domain of stargazin containing a
consensus myristoylated motif at its N terminus (myrSA), instead
of the transmembrane-domain sequence, and confirmed its
migration at the expected molecular weight in transfected CHO
cells (Figure S5C). The molecular weight of wild-type stargazin
was similar to that of StargazinSD, which indicates that wild-
type stargazin was nearly fully phosphorylated in CHO cells
(Figure S5C).
The coexpression of various stargazin mutants with mCherry-
tagged R-pre, which is a marker of negatively charged plasma
membranes (Yeung et al., 2006, 2008), revealed that myrSA
was localized at the plasma membrane, together with
mCherry-R-pre, whereas GFP, the cytoplasmic domain of Star-
gazinSD, and wild-type with myristoylated motif and GFP (myrSD
and myrSTG) distributed in the cytoplasm (Figure 5C). Further-
more, addition of the cationic lipid sphingosine translocated
myrSA from the plasmamembrane to the cytoplasm (Figure 5D).
These results indicate that the cytoplasmic domain of Starga-
zinSA interacted with the plasma membrane/lipid bilayers via
electrostatic interactions.
Cationic Lipids Enhanced the Synaptic Activity of AMPA
Receptors in a Stargazin Phosphorylation-Dependent
Manner
Next, we explored the roles of the interaction of stargazin with
lipid bilayers on AMPA receptor activity in neurons. To explore
the effects of stargazin dissociation from lipid bilayers on AMPA
receptor activity, we prepared cerebellar granule neurons from
StargazinSD and StargazinSA mice. Insertion of the cationic lipid
sphingosine into neuronal plasma membranes was confirmed
by the detection of the localization of fluorescent NBD-labeled
sphingosine (Figure 6A). Sphingosine treatment significantly
increased AMPA receptor-mediated mEPSCs frequency in all
neurons to a similar extent (Figure 6B), and, as proposed
recently, this sphingosine-mediated frequency enhancement
might represent modulation of the vesicle fusion complex (Darios
et al., 2009). Importantly, sphingosine increased mEPSC ampli-
tude (Figure 6C) without changing the decay kinetics of mEPSCs
in neurons from StargazinSA mice (Figure 6D). In contrast, a
similar increase in amplitude was not observed in neurons from
StargazinSD and wild-type mice (Figure 6C). AMPA receptor-
mediated mEPSCs in wild-type neurons were not modulated
by addition of cationic lipids, as we found that stargazin is highly
phosphorylated in cultured neurons (Kim et al., 2010). Because
we added tetrodotoxin (1 mM), AP-5 (100 mM), and picrotoxin
(100mM) to the extracellular recording solution, increase in AMPA
receptor-mediated mEPSC amplitudes are mediated by AMPA
receptor complex itself, but not by calcium-signaling cascade
or complex neuronal activations. One concern regarding the
experiments that used sphingosine is that sphingosine increased
mEPSC frequency robustly (Figure 5B), as described previously
(Darios et al., 2009). This robust change in mEPSC frequency
might have some additional effects. Therefore, we used another
cationic lipid, squalamine (Figures 6B and 6E). Similarly, squal-
amine increased mEPSC amplitude in StargazinSA neurons, but
not in StargazinSD andwild-type neurons. ThemEPSC amplitude
in StargazinSA in the presence of squalamine was similar to that
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Figure 5. PSD-95 Binding Requires Stargazin Dissociation from Lipid Bilayers
The cationic lipid lipofectamine increased the interaction between StargazinSA (SA) and PSD-95.
(A) Shown is the experimental scheme for examining the effects of cationic lipids on stargazin (STG) binding to PSD-95. Lipofectamine (100 mM) was added to
a stargazin-conjugated liposome and PSD-95 mixture. Stargazin-bound and unbound PSD-95 were separated by sucrose gradient centrifugation.
(B) PSD-95 did not bind StargazinSA in the PC/PA liposomes. Upon addition of lipofectamine, PSD-95 bound the StargazinSA from liposomes but not the
StargazinSA D4. The interaction between the StargazinSD-containing liposomes and PSD-95 was unaltered by lipofectamine. Notably, the weak signal observed
for the StargazinSA D4 was also observed in liposomes conjugated with cysteine alone, which suggests that this weak signal is nonspecific (Figure S5).
(C) The cytoplasmic domain of stargazin localized at the plasma membrane in a phosphorylation-dependent manner. The cytoplasmic domains of stargazin
and mutants were tagged with a myristoylation motif at the N terminus, to mimic the localization of the cytoplasmic domain near a transmembrane domain in
stargazin, and with GFP at the C terminus, to monitor its distribution (myrSTG), and expressed in CHO cells together with mCherry-R-pre, which interacts
with negatively charged membranes. The myristoylated StargazinSA mutant (myrSA) colocalized with mCherry-R-pre, whereas GFP alone, myrSD, and myrSTG
did not. The relative distribution of stargazin was analyzed relative to that of mCherry-R-pre.
(D) The cationic lipid sphingosine translocated myrSA from the plasma membrane to the cytoplasm, similarly to R-pre. Addition of the cationic lipid sphingosine
(100 mM for 5–20 min) induced the relocalization of myrSA from the plasma membrane to the cytoplasm. The relative distribution of stargazin and R-pre was
shown after adjustment of total amount of signal from single cell as 1 because total amount of proteins were not changed before or after addition of cationic lipid.
All data are shown as means ± SEM (n = 10 cells).
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Lipids Regulate AMPA Receptors through TARPsin StargazinSD. Therefore, we concluded that cationic lipids
consistently increased the mEPSC amplitude in StargazinSA
neurons, but not in StargazinSD neurons. Next, we measured
AMPA-evoked currents to monitor total AMPA receptor activity
at the cell surface and found that the AMPA-evoked currents
before and after treatment with cationic lipids were not different
in neurons from StargazinSA and StargazinSD mice, which
suggests that the increase in synaptic AMPA receptor activity
was diffused laterally at the cell surface (Figure 6F).
As AMPA receptor activity is dependent on the level of
stargazin in cerebellar granule cells, we measured changes inexpression of stargazin at the PSD. We treated neurons with
sphingosine and fractionated synaptic and non-synaptic
proteins. We found that StargazinSA was upregulated in the PSD
fraction, whereas StargazinSD was not (Figures 7A and 7B).
Because the synaptic localization of stargazin requires its inter-
action with PSD-95, we measured the interaction of PSD-95
with stargazin after addition of the cationic lipid using coimmu-
noprecipitation experiments. However, solubilization of PSD-
95 from neurons requires the use of a strong detergent, such as
1% SDS, which breaks the interaction of PSD-95 with stargazin.
Therefore, we used a chemical crosslinker to detect theNeuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc. 761
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Figure 6. Cationic Lipids Enhance Synaptic Activity of AMPA Receptors in a Stargazin Phosphorylation-Dependent Manner
(A) The cationic lipid sphingosine-NBD inserts into neuronal membranes. Sphingosine-NBD (2.5 mM) or vehicle (ethanol) was added to cerebellar granule cells and
analyzed by confocal microscopy. Top panels, DIC; bottom panels, NBD channel.
(B–D) AMPA receptor-mediated mEPSCs were recorded from cerebellar granule cells from StargazinSA (SA), StargazinSD (SD), and wild-type mice (WT) before
and after addition of cationic lipids, sphingosine (2.5 mM), or squalamine (2.5 mM). Shown are the representative traces (B), mean amplitude (C), and weighted t (D)
of AMPA receptor-mediated mEPSC from each genotype before and after sphingosine addition. In StargazinSA mice, the amplitude of mEPSC increased upon
addition of sphingosine, but no changes in decay kinetics were observed. No similar increase in amplitude was observed for wild-type and StargazinSD mice (n =
164–188 and 1626–1869 events from 13–15 cells for each genotype before and after sphingosine treatment, respectively). ***p < 0.005.
(E) Mean amplitude of AMPA receptor-mediated mEPSC from each genotype before and after squalamine addition (2.5 mM) [n = 48 (before squalamine) and n =
169 (after squalamine) events from six StargazinSA cells; n = 49 (before squalamine) and n = 160 (after squalamine) events from seven StargazinSD cells]. *p < 0.01.
(F) AMPA-evoked currents did not change upon addition of sphingosine (n = 13–15 cells for each genotype before and after sphingosine treatment, respectively).
Data are shown as means ± SEM.
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Lipids Regulate AMPA Receptors through TARPsinteraction of PSD-95 with stargazin. We added a crosslinker
(DSP) to cerebellar granule cells treated with or without sphingo-
sine. Solubilized proteins were subjected to immunoprecipita-
tion with anti-stargazin antibody. To avoid an artificial inter-
action of stargazin with PSD-95 during incubation, we added
100 mM of a 10-mer peptide from the C terminus of stargazin
(NTANRRTTPV), which allowed the in vivo detection of cross-
linked complexes exclusively. We detected protein complexes
exclusively in neurons (and not in test tubes) (Figure 7C). Further-
more, we found that sphingosine treatment increased the inter-
action of PSD-95 with StargazinSA, but not with StargazinSD,
without changes in the total levels of protein expression (Figures
7D and 7E). These results indicate that the electrostatic interac-
tion between stargazin and the negatively charged lipid bilayers
inhibits interaction between stargazin and PSD-95 and that
dissociation of stargazin from the lipid bilayer increases AMPA762 Neuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc.receptor activity at synapses via lateral diffusion and interaction
with PSD-95 (Figure 7F).
DISCUSSION
The results of this study demonstrate that stargazin phosphory-
lation regulates synaptic AMPA receptor activity in vivo, using
stargazin knockin mice in which the phosphorylatable serine
residues were mutated to aspartate (phosphomimic) or alanine
(non-phosphomimic) residues. Stargazin interacts with the
negatively charged lipid bilayer in a phosphorylation-dependent
manner. This lipid-stargazin interaction inhibits the binding of
stargazin to PSD-95. Cationic lipids dissociate stargazin from
lipid bilayers and enhance the activity of synaptic AMPA recep-
tors in a stargazin phosphorylation-dependent manner. These
findings establish that negatively charged lipid bilayers and
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Figure 7. Cationic Lipids Enhance Translocation of Stargazin to Synapses in a Stargazin Phosphorylation-Dependent Manner
(A and B) Treatment with a cationic lipid increased the synaptic expression of StargazinSA, but not of StargazinSD, without changes in the synaptic expression of
PSD-95. Cerebellar granule cells from StargazinSA and StargazinSD mice were treated with and without sphingosine (10 mM for 5 min), which was followed by
fractionation of soluble Triton X-100 (Syn/Tx) and insoluble PSD-enriched (PSD) fractions. Stargazin (STG) translocated into the PSD fraction after addition of
sphingosine in neurons from StargazinSA, but not StargazinSD, mice, without changes in PSD-95 and synaptophysin (Sph). Protein amounts were quantitated
using ImageJ. Data are shown as means ± SEM (n = 6).
(C) Stargazin immunoprecipitated PSD-95 from cerebellar granule cells treated with a crosslinker (CL), which indicated that stargazin did not interact artificially
with PSD-95 during incubation (in test tubes) under this experimental condition.
(D) Cationic lipid treatment (10 mM sphingosine, 5 min with 2 mM TTX) increased the interaction between PSD-95 and StargazinSA, but not StargazinSD, without
changes in the total levels of protein expression.
(E) Quantitative analyses showed that total protein expression was not significantly different after the treatment with cationic lipids, whereas the level of PSD-95
immunoprecipitated with the anti-stargazin antibody was significantly increased. Data are shown as means ± SEM (n = 3). *p < 0.01.
(F) A model for the TARP phosphorylation-mediated regulation of synaptic AMPA receptors via lipid bilayers. The interaction of negatively charged lipid bilayers
with stargazin inhibits the binding of stargazin to PSD-95. Dissociation of lipids from phosphorylated stargazin leads to its binding to PSD-95 at synapses.
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Lipids Regulate AMPA Receptors through TARPsstargazin phosphorylation are critical modulators for synaptic
AMPA receptor activity.
Roles of Multiple Phosphorylation Sites in TARPs
Stargazin has nine phosphorylated serine residues (Tomita et al.,
2005b), and these phosphorylation sites are well conserved
among class I TARPs (stargazin/g-2, g-3, g-4, and g-8). Indeed,
g-3 is phosphorylated at sites that correspond well to the sites of
stargazin in neurons (Tomita et al., 2005b). In this study, we
mutated all nine phosphorylated serine residues either to as-
partic acid as a phosphomimic stargazin or to alanine as a
non-phosphomimic stargazin and found that stargazin inter-
acted with negatively charged lipid bilayers in a phosphoryla-
tion-dependent manner (Figure 3). These nine phosphorylated
residues surround eight of the basic arginine residues, which
recognize negative charges on lipid bilayers. Therefore, acidic
phosphorylated residues inhibit interactions between the basic
arginine residues in stargazin and the negatively charged lipid
bilayers. Because stargazin recognizes lipid bilayers by electro-static interactions, the stargazin interaction with lipid bilayers is
likely to depend on the number of stargazin phosphorylated resi-
dues to be graded manner instead of binary on-off manner.
Because the dissociation of stargazin from lipid bilayers
enhanced the binding of stargazin to PSD-95 (Figures 4 and 5),
graded interactions between stargazin and lipid bilayers could
induce graded interactions between stargazin and PSD-95,
which could lead to graded synaptic transmission. Graded inter-
actions between stargazin and lipid bilayers may serve as a
‘‘molecular rheostat’’ and provide neurons with more dynamic
synaptic transmission capabilities.
The Mechanisms Underlying the Synaptic Targeting
of Nonphosphorylated TARPs
In this study, we found that phosphorylated stargazin preferen-
tially localized at synapses (Figure 1). Whereas disruption of star-
gazin expression in Stargazer mice resulted in no discernible
AMPA receptor activity from the cerebellar granule cells, neurons
of non-phosphorylated stargazin knockins had detectableNeuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc. 763
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Lipids Regulate AMPA Receptors through TARPssynaptic AMPA receptor activity, indicating that non-phosphor-
ylated stargazin could localize at synapses with AMPA recep-
tors. The stargazin-AMPA receptor complex localized to
synapses through PSD-95 binding, and lipid bilayers inhibited
stargazin binding to PSD-95, suggesting that non-phosphory-
lated stargazin somehow did not interact with lipid bilayers.
A possible molecular mechanism to explain these phenomena
is that an unidentified molecule may bind to the non-phosphory-
lated form of the TARPs at synapses, and this interaction may
dissociate TARPs from the lipid bilayers, leading to TARP binding
with PSD-95. Another possible mechanism could be that the
interaction between TARPs and lipid bilayers is weaker than
the interaction between TARPs and PSD-95. Therefore, once
bound to PSD-95 at synapses, the TARPs are difficult to disso-
ciate. Characterization of the lipid composition at synapses is
required for further investigation of these alternatives.
There are 64 amino acids (aa) between the most C-terminal
phosphorylation site among nine phosphorylated residues and
the C-terminal PDZ domain-binding motif (TTPV). It remains
unclear how stargazin phosphorylation affects the PDZ binding
at 64 aa away. We currently considered two possibilities. First,
Schnell et al. (2002) showed that the point mutation in the second
PDZ domain of PSD-95 is sufficient to block interaction with star-
gazin. Since the second PDZ domain of PSD-95 locates at the
position of 161–243 aa, 64 aa from stargazin is not enough to
reach its binding pocket and dissociation of stargazin phosphor-
ylation sites from lipid bilayers is necessary for its binding to
PSD-95. Second, 64 aa take fully compacted structure and not
enough distance to interact with endogenous PSD-95. To fully
answer these possibilities, crystal structure at the atomic level
is required.
Lipid Bilayers as Novel Regulators of PDZ Domain
Binding
In addition to identifying themolecular machinery that modulates
AMPA receptor activity, the results of this study establish lipids as
novel regulators of the interactions between PDZ domains and
the PDZ domain-binding motif. The lipid composition of the inner
leaflet of plasma membranes is regulated by various enzymes
(Di Paolo and De Camilli, 2006), and changes in lipid composi-
tion could affect the TARP/MAGUKs interaction. In the human
genome, 96 proteins contain PDZ domains and many proteins
have the consensus PDZ domain-binding motif (Venter et al.,
2001), suggesting that numerous combinations between the
PDZ domains and possible binding partnersmay exist. However,
PDZ interactions appear to be tightly regulated in vivo. Whereas
stargazin contains a typical class I PDZ-binding motif, it does
not constitutively bind to PDZ proteins outside of synapses
(Fukata et al., 2005; Vandenberghe et al., 2005). We propose
that the lipid bilayer functions as a regulator for controlling the
PDZdomain and its bindingmotif andour findingsprovide a novel
mechanism for the regulation of PDZ domain interactions.
Contribution of Lipid Bilayers to Synaptic AMPA
Receptor Activity
We propose that negatively charged lipid bilayers function as
modulators of AMPA receptor activity at synapses. Inositol
phospholipids are some of the best-characterized negatively764 Neuron 66, 755–767, June 10, 2010 ª2010 Elsevier Inc.charged lipids and they strongly interact with stargazin
(Figure 3C). Inositol phospholipids are modulated by various
phosphatases and kinases; the metabolites contain a specific
number of phosphates and are charged negatively (Di Paolo
and De Camilli, 2006). Because stargazin recognizes negative
charges on lipid bilayers, rapid modulation of lipid composition
in the inner leaflet of plasma membranes could regulate the
distribution of synaptic AMPA receptors through TARPs. Indeed,
we showed here that the addition of cationic lipids increased
AMPA receptor-mediated EPSCs in a TARP phosphorylation-
dependent manner. Therefore, relocation of polar lipids (phos-
phatidylserine and phosphatidylglycerol) or negatively charged
lipids to the plasma membrane, or metabolism of phosphates
on lipids, could modulate the activity of synaptic AMPA recep-
tors. Lipid composition of the plasma membranes at synapses
and modulation of the lipid composition may reveal novel mech-
anisms for regulating the AMPA receptors at synapses. Further
investigation of the lipid composition at synapses, PSDs, spines,
and dendrites is required.
We found that themini amplitude and IAMPA/INMDA ratio in Star-
gazinSD mice were 1.253 and 33 the level of that in StargazinSA
mice, respectively (Figures 2A and 2F). In addition, we observed
larger AMPA-evoked currents in StargazinSD (Figure S2F).
Because overexpression of StargazinWT, StargazinSA, and Star-
gazinSD increased surface AMPA receptor activity to a similar
level in neurons (Tomita et al., 2005b), one possible mechanism
for the enhancement of AMPA-evoked currents in StargazinSD
is that all stargazin might traffic to the cell surface at a similar
level, but StargazinSD overflowed from synapses and floated
on the surface or StargazinSD mutation escaped from protein
degradation pathways.
It has been shown that PICK1 interacts with lipids via the BAR
domain and the PDZ domain, independently (Jin et al., 2006; Pan
et al., 2007; Steinberg et al., 2006). Furthermore, overexpression
of PICK1 mutants that disrupt lipid interaction modulates the
surface expression of AMPA receptors. Because we did not
observe any changes in total AMPA receptor activity at the cell
surface, as assessed by AMPA-evoked currents after addition
of cationic lipids, the effects of cationic lipids on synaptic
AMPA receptor activity seem to be independent from PICK1.
The interaction of PICK1 with lipids may play a role in other brain
regions.
TARP Phosphorylation in Synaptic Plasticity
Neuronal activity modulates synaptic strength, and Hebbian or
non-Hebbian types of synaptic plasticity have been established,
including LTP, long-term depression, and synaptic scaling
(Collingridge et al., 2004; Kessels and Malinow, 2009; Lisman,
2003; Malenka and Bear, 2004; Nelson and Turrigiano, 2008).
The molecular mechanisms underlying these types of synaptic
plasticity have been extensively studied but the substrates of
synaptic plasticity have not been fully understood. Several
studies of synaptic plasticity in gene-targeting mice have sug-
gested that the AMPA receptor itself may serve as a phosphory-
lated substrate in distinct forms of plasticity (Lee et al., 2003).
However, mice in which each subunit of the AMPA receptor is
disrupted also show synaptic plasticity, suggesting that there
may be other substrates of plasticity outside of the AMPA
Neuron
Lipids Regulate AMPA Receptors through TARPsreceptor itself. TARP may be a reasonable candidate as
a substrate for synaptic plasticity because TARP phosphoryla-
tion is regulated upon neuronal activity (Tomita et al., 2005b)
and TARP phosphorylation induces TARP binding to PSD-95.
To directly examine this possibility, analysis of synaptic plasticity
in mice carrying mutations in the TARP phosphorylation sites is
required. Here, we mutated stargazin as a representative TARP
in order to evaluate the roles of TARP in basal synaptic transmis-
sion because loss of stargazin disrupts the activity of synaptic
AMPA receptors of cerebellar granule cells—the purest system
available for evaluating TARP functions at synapses (Chen
et al., 2000; Hashimoto et al., 1999). However, cerebellar granule
cells are not an appropriate system for studying synaptic plas-
ticity; hippocampal pyramidal cells may be more useful. Indeed,
LTP was reduced by 75% in mice in which TARP/g-8, a hippo-
campus-abundant TARP isoform, was knocked out (Rouach
et al., 2005). Therefore, TARP/g-8 knockin mice, which carry
mutations in the phosphorylation sites of TARP/g-8, are needed
to study the roles of TARP phosphorylation in synaptic plasticity.
EXPERIMENTAL PROCEDURES
Antibodies
Rabbit polyclonal antibodies were used against the following proteins: GluA1,
GluA2/3, GluA4, and Pan-TARP (Millipore); TTPV and stargazin (Tomita et al.,
2003); and thioredoxin (Sigma-Aldrich). Polyclonal antisera toGSTwere affinity
purified on agarose columns containing the GST proteins. Mouse monoclonal
antibodies were used against PSD-95 (ABR), synaptophysin, GST (Sigma-
Aldrich), PSD-95, PSD-93, SAP97, and SAP102 (NeuroMab).
Protein-Lipid Overlay Assay
Membrane lipid strips (Echelon) were used for the protein overlay assay. After
blocking, the membrane strips were incubated with GST-fused proteins, fol-
lowed by western blotting with anti-GST antibody.
Preparation of Liposomes
All synthetic lipids were purchased from Avanti Polar Lipids. Brain lipid was
purchased from Sigma-Aldrich. Lipids were dissolved in chloroform and
evaporated using argon gas in order to prepare a lipid film. The lipid film
was dissolved in TE buffer, freeze-thawed, and passed though a 100 nm poly-
carbonate membrane using a mini-extruder (Avanti Polar Lipids). Liposome
size was confirmed by light scattering.
Liposome-Protein Interaction Assay
Liposomes and purified recombinant proteins were incubated in TBSE buffer
[10 mM Tris (pH 7.4), 150 mM NaCl, and 1 mM EDTA]. Liposome-protein
mixtures were adjusted to 1.2 M sucrose/TBSE by adding 2 M sucro-
se/TBSE, and were then overlaid with 0.9 M sucrose/TBSE and 0 M
sucrose/TBSE. Sucrose gradients were subjected to ultracentrifugation and
the interphase between the 0 M and 0.9 M sucrose layers and the phase
containing 1.2 M sucrose layer were recorded as ‘‘bound’’ and ‘‘unbound,’’
respectively.
Protein Conjugation to Liposomes
For the covalent conjugation of recombinant proteins, liposomes were
prepared with 5% MPB-PE (Avanti Polar Lipids) and incubated with recombi-
nant stargazin proteins. Free MPB was blocked with cysteine and then the
protein/MPB liposome mixtures were subjected to sucrose gradient centrifu-
gation with 1 M NaCl to remove unconjugated proteins from the liposome.
The upper liposome fraction was collected and subject to ultracentrifugation
at 100,0003 g. The pellet was resuspended in TBSE as a liposome with cova-
lently conjugated protein. To control the conjugation site of stargazin proteins,
we introduced an extra cysteine residue between the thrombin cleavage siteand the cytoplasmic domain of stargazin. In addition, we substituted a serine
for the cysteine at position 302 in order to avoid MPB-cysteine conjugation
within the stargazin cytoplasmic domain, i.e., only one cysteine residue was
present in the recombinant stargazin cytoplasmic domain. A cysteine residue
at position 302 in the cytoplasmic domain of stargazin is not involved in AMPA
receptor activity at synapses (Figures S4C and S4D). Proteins purified from
E. coliwere cleaved with thrombin and the resulting His6-thioredoxin products
were absorbed with nickel agarose (QIAGEN) to purify the non-tagged cyto-
plasmic domains of stargazin.
Whole-Cell Recording from Cerebellar Slices
Sagittal cerebellar slices with a thickness of 200 mm were prepared from star-
gazer, stargazin knockin, and wild-type mice (P21–P30). Patch-clamp record-
ings from granule cells that were identified visually in cerebellar slices were
performed as described previously (Hashimoto et al., 1999). The resistance
of patch pipettes was 5–10 MU when filled with an intracellular solution
composed of 130 mM caesium methanesulfonate, 5 mM HEPES, 5 mM Mg-
ATP, 0.2 mM Na-GTP, 20 mM TEA-CL, and 5 mM EGTA (pH 7.3, adjusted
with CsOH). The composition of the standard bathing solution was 125 mM
NaCl, 2.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1.2 mM NaH2PO4, 25 mM
NaHCO3, and 25 mM glucose; this solution was bubbled continuously with
a mixture of 95% O2 and 5% CO2. Bicuculline (10 mM) and picrotoxin
(100 mM) were always present in the saline solution, to block spontaneous
IPSCs. Stimulation and on-line data acquisition were performed using the
Clampex program (version 10.2; Axon Instruments). Signals were filtered at
3 kHz and digitized at 20 kHz. For stimulation ofmossy fibers in the cerebellum,
the stimuli were delivered through a glass pipette with a tip 5–10 mm in
diameter that was filled with standard saline solution. Paired-pulse facilitation
was performed via the delivery of two stimuli at an interval of 40 ms. Square
pulses (duration, 0.1 ms; amplitude, 5 V) were applied using a World Precision
Instruments A365 constant current stimulator, for focal stimulation. All record-
ings were performed at room temperature. mEPSC amplitude and inter-event
interval from each cell was averaged. Subsequently, the average mEPSC
amplitude and inter-event interval from each cell was used for statistical anal-
ysis comparingmEPSCs from each genotype. Both t test and ANOVA followed
by Tukey’s test were used; cumulative distribution was compared by Kolmo-
gorov-Smirnov test.
Membrane Interaction Assay via Protein Localization
The GFP-R-pre and mCherry-R-pre constructs were generated using a
standard PCRmethod with the following synthetic oligonucleotides: 50-TACCT
CGAGGAAGGATGGCCAGAGATGGTCGGCGCAGGAGACGGCGCG-30 and
50-TACGGATCCTTACATAATTACACATCTGGCCCTAGCGCGCCGTCTCCT-30.
myrSTG-GFP, myrSA-GFP, and myrSD-GFP were generated using a PCR
method with primers containing the myristoylation consensus sequence of
MARCKs (Towler et al., 1988). CHO cells were plated onto poly-D-lysine-
coated LAB-TEK 4 well chambered coverglass (Nunc). After 16–18 hr of
transfection, cells were observed using a Zeiss LSM510 Meta confocal
microscope.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
neuron.2010.04.035.
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